loadpatents
name:-0.0071380138397217
name:-0.011758804321289
name:-0.00092196464538574
ARTH; Christoph Patent Filings

ARTH; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for ARTH; Christoph.The latest application filed is for "polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine".

Company Profile
2.14.9
  • ARTH; Christoph - Monheim DE
  • Arth; Christoph - Dusseldorf DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine
App 20190314294 - WOLFF; Hans-Michael ;   et al.
2019-10-17
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Grant 10,350,174 - Wolff , et al. July 16, 2
2019-07-16
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Grant 10,130,589 - Wolff , et al. November 20, 2
2018-11-20
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine
App 20180263921 - WOLFF; Hans-Michael ;   et al.
2018-09-20
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-crystalline Form Of Rotigotine
App 20180147154 - Wolff; Hans-Michael ;   et al.
2018-05-31
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Grant 9,925,150 - Wolff , et al. March 27, 2
2018-03-27
Pharmaceutical compositions comprising Fesoterodine
Grant 9,364,541 - Mika , et al. June 14, 2
2016-06-14
Pharmaceutical Compositions Comprising Fesoterodine
App 20130296423 - MIKA; Hans-Jurgen ;   et al.
2013-11-07
Pharmaceutical compositions comprising fesoterodine
Grant 8,501,723 - Mika , et al. August 6, 2
2013-08-06
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-crystalline Form Of Rotigotine
App 20120322845 - Wolff; Hans-Michael ;   et al.
2012-12-20
Pharmaceutical compositions comprising fesoterodine
Grant 8,088,398 - Mika , et al. January 3, 2
2012-01-03
Pharmaceutical compositions comprising fesoterodine
Grant 7,807,715 - Arth , et al. October 5, 2
2010-10-05
Pharmaceutical Compositions Comprising Fesoterodine
App 20100130606 - MIKA; Hans-Jurgen ;   et al.
2010-05-27
Pharmaceutical Compositions Comprising Fesoterodine
App 20090117159 - MIKA; Hans-Jurgen ;   et al.
2009-05-07
Pharmaceutical compositions comprising fesoterodine
App 20080138421 - Arth; Christoph ;   et al.
2008-06-12
Transdermal therapeutic system TTS containing tolterodine
Grant 6,783,769 - Arth , et al. August 31, 2
2004-08-31
Transdermal therapeutic system (TTS) for administering sexual steroid hormones
Grant 6,562,367 - Wolff , et al. May 13, 2
2003-05-13
Therapeutical system for transdermal delivery of levonorgestrel
Grant 6,555,131 - Wolff , et al. April 29, 2
2003-04-29
Transdermal therapeutic system (TTS) containing oxybutynin
Grant 6,555,129 - Arth , et al. April 29, 2
2003-04-29
Transdermal therapeutic system containing pergolide
Grant 6,461,636 - Arth , et al. October 8, 2
2002-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed